Fluorodeoxyglucose (FDG) positron emission tomography combined with computed tomography (PET/CT) has become indispensable in the management of haematological malignancies. By visualising and ...

For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...

Staging locally advanced breast cancer patients with 18 F-labeled fluorodeoxyglucose (FDG) PET-CT detected more distant metastases -- and thus reduced the number of patients who received combined ...

Use of PPV of [18F]FAPI-74 PET to identify FAP expression in gastrointestinal cancers: Results from a prospective multicenter phase 2 study. Diagnostic statistics for metastasis for 18F-FDG and ...

A research team led by the Medical University of Vienna has demonstrated in a recent study that the biological characteristics of a subgroup of head and neck tumors - which are very aggressive in many ...

Multiple antigen stimulating cellular therapy (MASCT)-I for metastatic urothelial carcinoma (mUC): A multicenter, phase I study (MASCT-I-1001). This is an ASCO Meeting Abstract from the 2023 ASCO ...

The purpose of this e-learning module is to develop a consensus based on evidence from existing systematic reviews, to make health care providers aware of the value and the appropriateness of the use ...

Fluorodeoxyglucose (FDG) has proven benefits as a positron emission tomography (PET) radiopharmaceutical in oncology. However, it has limitations in the assessment of certain tumours, above all (but ...

A cyclotron is a complicated device that makes very short-lived radioisotopes. These radioisotopes can be used to manufacture radiopharmaceuticals for positron emission tomography (PET) imaging. PET ...

Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of The ...